Semaglutide: A Complete Guide to Uses, Results, Side Effects, and Cost

What Semaglutide Is and How It Works

Semaglutide belongs to a class of drugs called GLP-1 receptor agonists. It mimics glucagon-like peptide-1, a hormone your gut naturally releases after you eat. By activating GLP-1 receptors, semaglutide prompts your pancreas to release insulin when blood sugar rises, slows how quickly food leaves your stomach, and signals your brain to feel full sooner and stay full longer.

That combination produces two clinical effects: better blood sugar control for people with type 2 diabetes, and significant appetite reduction for people managing weight. The medication does not burn fat directly. It makes sustained calorie reduction possible by quieting the hunger and food-focused thoughts that typically sabotage weight loss efforts. Our what is semaglutide guide walks through the mechanism in more detail, and our piece on how GLP-1s change appetite signals explains why the food noise goes quiet for most patients.

Brand Names and Formulations

Semaglutide is the active ingredient in three FDA-approved products, each designed for a specific use case. Understanding the differences helps you and your physician match the right formulation to your goals.

Ozempic is the most prescribed semaglutide product, largely because of widespread off-label use for weight loss. Wegovy uses the same molecule at a higher maximum dose and is specifically approved for weight management. Rybelsus offers a needle-free option for diabetes but requires strict fasting instructions to absorb properly. Our Ozempic comprehensive guide and Wegovy uses and dosage breakdown cover each in detail, and if you are weighing pills against injections, our pills vs shots comparison explains why injectables still outperform oral semaglutide for most patients.

How Much Weight You Can Lose

The STEP clinical trials established what most patients can expect from semaglutide for weight loss. In STEP 1, participants on weekly 2.4 mg semaglutide lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% for placebo. For someone starting at 220 pounds, that works out to roughly 33 pounds. Diabetes trials (SUSTAIN) showed smaller but still meaningful weight reductions of 4 to 6%.

Results are not linear. Most patients see the fastest loss in the first three to four months, then a gradual taper as the body adjusts. A plateau at six to nine months is normal and rarely means the medication has stopped working. Our full breakdown of GLP-1 weight loss results shows what typical month-by-month trajectories look like, and if your progress stalls, the Ozempic not working guide walks through what to check before changing treatment.

Weight loss on semaglutide depends heavily on what you do alongside the medication. Patients who prioritize protein intake and maintain resistance training tend to lose more fat and less muscle, which matters for long-term results and metabolic health.

Side Effects and What to Expect

Most semaglutide side effects are gastrointestinal and appear during the first few weeks, especially after dose increases. The slow titration schedule (starting at 0.25 mg and increasing every four weeks) exists specifically to reduce side effect intensity.

Serious but rare side effects include pancreatitis, gallbladder disease, and severe gastroparesis. Semaglutide carries a boxed warning for thyroid C-cell tumors based on rodent studies, so it is not recommended for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome. For a full breakdown of what to watch for and how to manage the common issues, see our GLP-1 side effects overview and the guide to managing nausea on Ozempic and Wegovy.

Cosmetic concerns like facial changes and hair shedding are real but are typically related to rapid weight loss rather than the drug itself.

Cost and Access

Semaglutide pricing varies more than almost any other prescription drug in the US. The same molecule can cost $50 with commercial insurance or more than $1,400 out of pocket without it.

With commercial insurance and prior authorization, most patients pay between $25 and $250 per month. Without insurance, list prices for Ozempic run around $997 and Wegovy around $1,349 before manufacturer savings cards. Telehealth programs that prescribe compounded semaglutide typically charge $199 to $399 per month, often bundling the physician consultation. Our 2026 GLP-1 cost guide tracks current pricing across channels, and the insurance coverage guide explains what plans are covering this year and what prior authorization typically requires.

For most patients, the fastest path to treatment is a telehealth intake. You can check eligibility and pricing in about five minutes.